Protect From Light
It is strictly contraindicated in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, or a history of drug abuse
In late 2023 the FDA placed BPC-157 on the 503A bulks list "Category 2," which limits compounding pharmacy access
The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl [PMID: 37814337] Laboratory literature summary: The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease
Adv Mater 35:e2304967 Deng Y, Gao Y, Li T, Xiao S, Adeli M, Rodriguez RD, Geng W, Chen Q, Cheng C, Zhao C (2023) Amorphizing metal selenides-based ROS biocatalysts at surface nanolayer toward ultrafast inflammatory diabetic wound healing